The critical relationship between compliance and the management of infectious diseases

Clinical Microbiology and Infection

Volumn 4, Issue 5, 1998, Pages 275-279

  Erwin, Jo ^a,b   Peters, Barry S ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT;

ARTICLE; COMMUNICABLE DISEASE; HUMAN; PATIENT COMPLIANCE; PRIORITY JOURNAL;

EID: 0031830843     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1469-0691.1998.tb00056.x     Document Type: Article

References (27)

1. Meredith PA. Therapeutic implications of drug "holidays". Eur Heart J 1996; 17(suppl A): 21-4.
2. Donovan JL, Blake DR. Patient non-compliance: deviance or reasoned decision-making? Social Sci Med 1992; 34: 507-13.
3. Urquhart J. Ascertaining how much compliance is enough with outpatient antibiotic regimens. Postgrad Med J 1992; 68(suppl 3): S49-58.
4. Gordis L, Markowitz M, Lihenfeld AM. The inaccuracy in using interviews to estimate patient reliability in taking medications at home. Med Care 1969; 7: 49-54.
5. Pullar T, Kumar S, Tindall H, Feely M. Time to stop counting the tablets? Clin Pharmacol Ther 1989; 46: 163-8.
6. Feely M, Cooke J, Price D, et al. Low-dose phenobarbitone as an indicator of compliance with drug therapy. Br J Clin Pharmacol 1987; 24: 77-83.
7. Feinstein AR. On white-coat effects and the electronic monitoring of compliance. Arch Intern Med 1990; 150: 1377-8.
8. Greenberg RN. Overview of patient compliance with medication dosing: a literature review. Clin Ther 1984; 6: 592-9.
9. Sackett DL, Snow JC. The magnitude of compliance and non-compliance. In Haynes RB, Taylor DW, Sackett DL, eds. Compliance in health care. Baltimore: Johns Hopkins University Press, 1979: 11-12.
10. Cockburn J, Reid AL, Bowman JA, et al. Effects of intervention on antibiotic compliance in patients in general practice. Med J Aust 1987; 147: 324-8.
11. Kruse W, Eggert-Kruse W, Rampmaiere J, et al. Dosage frequency and drug-compliance behaviour - a comparative study on compliance with a medication to be taken twice or four times daily. Eur J Clin Pharmacol 1991; 41: 589-92
12. Pullar T, Birtwell AJ, Wiles PG, et al. Use of a pharmacologic indicator to compare compliance with tablets prescribed once, twice, or three times daily. Clin Pharmacol Ther 1988; 44: 540-5.
13. Kroenke K, Pinholt EM Reducing polypharmacy in the elderly. A controlled trial of physician feedback. J Am Geriatr Soc 1990; 38 31-6.
14. Ayd FJ Jr. Single daily dose of antidepressants. JAMA 1974; 230: 263-4.
15. Gadey MS. To be taken as directed. J R Coll Gen Pract 1968; 16: 39-44.
16. Cramer JA, Scheyer RD, Mattson RH. Compliance declines between clinic visits. Arch Intern Med 1990; 150: 1509-10.
17. Braithwaite A, Pechère JC. Pan-European survey of patients' attitudes to antibiotics and antibiotic use. J Int Med Res 1996; 24: 229-38.
18. Dixon WM, Stradling P, Wootton IDP. Outpatient PAS therapy. Lancet 1957; ii: 871-2.
19. Mehta S, Moore RD, Graham NM. Potential factors affecting adherence with HIV therapy. AIDS 1997; 11: 1665-70.
20. Patcher LM. Culture and clinical care: folk illness beliefs and behaviours and their implications for health care delivery. JAMA 1994; 271: 690-4.
21. Merry C, Clarke S, O'Leary A, et al. Improved compliance in HIV positive patients [abstract]. In: 3rd International Congress on Drug Therapy in HIV Infection, Birmingham, November 1996, 138.
22. Eldred L, Wu A, Chaisson RE, et al. Adherence to antiretroviral therapy in HIV disease [abstract 251]. In 4th Conference on Retroviruses and Opportunistic Infections, Washington, January 1997.
23. Favre O, Delacretaz E, Badan M, et al. Relationship between the prescriber's instructions and compliance with antibiotherapy in outpatients treated for an acute infectious disease. J Clin Pharmacol 1997; 37: 175-8.
24. Mazzullo JM III, Lasagna L, Griner PF. Variations in interpretation of prescription instructions. JAMA 1974; 227: 929-31.
25. Stall M, Hoff C. Decisions to get HIV tested and to accept antiviral therapies among gay/bisexual men: implications for secondary prevention efforts. J Acquired Immune Defic Synd Human Retrovirol 1991; 32: 1161-7.
26. Evans L, Spelman M. The problem of non-compliance with drug therapy. Drugs 1983; 25: 63-76.
27. Royal Pharmaceutical Society. From compliance to concordance: achieving shared goals in medicine taking. London: Royal Pharmaceutical Society, 1997.